Literature DB >> 10995781

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

N F Voelkel1, R M Tuder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10995781      PMCID： PMC381402          DOI： 10.1172/JCI11144

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  36 in total

1.  THE TERMINAL PORTION OF THE PULMONARY ARTERIAL TREE IN PEOPLE NATIVE TO HIGH ALTITUDES.

Authors:  J ARIAS-STELLA; M SALDANA
Journal:  Circulation       Date:  1963-11       Impact factor: 29.690

Review 2.  Pulmonary hypertension and inflammation.

Authors:  R M Tuder; N F Voelkel
Journal:  J Lab Clin Med       Date:  1998-07

3.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Authors:  L Taraseviciene-Stewart; Y Kasahara; L Alger; P Hirth; G Mc Mahon ; J Waltenberger; N F Voelkel; R M Tuder
Journal:  FASEB J       Date:  2001-02       Impact factor: 5.191

4.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.

Authors:  S D Lee; K R Shroyer; N E Markham; C D Cool; N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Authors:  M W Geraci; B Gao; D C Shepherd; M D Moore; J Y Westcott; K A Fagan; L A Alger; R M Tuder; N F Voelkel
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

Review 6.  Superoxide in the pulmonary circulation.

Authors:  A T Demiryürek; R M Wadsworth
Journal:  Pharmacol Ther       Date:  1999-12       Impact factor: 12.310

7.  Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Authors:  N F Voelkel; R M Tuder; K Wade; M Höper; R A Lepley; J L Goulet; B H Koller; F Fitzpatrick
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features.

Authors:  M Rabinovitch; W Gamble; A S Nadas; O S Miettinen; L Reid
Journal:  Am J Physiol       Date:  1979-06

9.  PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.

Authors:  S Ono; J Y Westcott; N F Voelkel
Journal:  J Appl Physiol (1985)       Date:  1992-09

10.  Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats.

Authors:  T C Isaacson; V Hampl; E K Weir; D P Nelson; S L Archer
Journal:  J Appl Physiol (1985)       Date:  1994-02
View more
  53 in total

1.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 2.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 3.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

4.  Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension.

Authors:  Zhiyuan Ma; Lan Mao; Sudarshan Rajagopal
Journal:  J Vis Exp       Date:  2016-04-11       Impact factor: 1.355

Review 5.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

Review 6.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 7.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

Review 8.  Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension.

Authors:  Laszlo Farkas; Martin Kolb
Journal:  Respiration       Date:  2013-03-22       Impact factor: 3.580

Review 9.  Vascular remodeling in pulmonary hypertension.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Mol Med (Berl)       Date:  2013-01-19       Impact factor: 4.599

Review 10.  RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.

Authors:  Scott A Barman; Shu Zhu; Richard E White
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.